374 participants
A Phase I/II Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Initial Efficacy of JS212 in Subjects With Advanced Malignant Solid Tumour
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2026-07-08
- Start Date:
- 2025-04-11
- Completion:
- 2027-12-31
Conditions
- Advanced Malignant Solid Tumours
Interventions
- DRUG
No Results Yet